Dyne Therapeutics (DYN) Prepaid Assets (2019 - 2026)
Dyne Therapeutics (DYN) recorded quarterly Prepaid Assets of $48.9 million in Q1 2026, up 204.97% quarter-over-quarter from $16.0 million in Q4 2025, and up 306.89% on a YoY basis from $12.0 million in Q1 2025.
Dyne Therapeutics (DYN) Prepaid Assets (2019 - 2026) Analysis & Trends
Dyne Therapeutics' Prepaid Assets history runs 8 years deep, the most recent figure standing at $48.9 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 306.89% year-over-year to $48.9 million; the TTM figure through Mar 2026 stood at $48.9 million (up 306.89% YoY), while the FY2025 annual figure was $16.0 million, down 5.8% from the prior year.
- Prepaid Assets was $48.9 million for Q1 2026 at Dyne Therapeutics, up from $16.0 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $48.9 million in Q1 2026 to a low of $5.4 million in Q2 2023.
- Historically, Prepaid Assets has averaged $15.5 million across 5 years, with a median of $12.7 million in 2024.
- Biggest YoY gain for Prepaid Assets was 434.77% in 2022; the steepest drop was 76.29% in 2022.
- A 5-year view of Prepaid Assets shows it stood at $9.6 million in 2022, then sank by 34.51% to $6.3 million in 2023, then soared by 171.09% to $17.0 million in 2024, then dropped by 5.8% to $16.0 million in 2025, then surged by 204.97% to $48.9 million in 2026.
- The last three Prepaid Assets figures came in at $48.9 million (Q1 2026), $16.0 million (Q4 2025), and $14.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Dyne Therapeutics | 3.00 Bn | 3.00 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.87 Mn |
| Dec 31, 2025 | 16.03 Mn |
| Sep 30, 2025 | 14.38 Mn |
| Jun 30, 2025 | 14.03 Mn |
| Mar 31, 2025 | 12.01 Mn |
| Dec 31, 2024 | 17.01 Mn |
| Sep 30, 2024 | 12.72 Mn |
| Jun 30, 2024 | 13.48 Mn |
| Mar 31, 2024 | 34.59 Mn |
| Dec 31, 2023 | 6.28 Mn |
| Sep 30, 2023 | 10.39 Mn |
| Jun 30, 2023 | 5.44 Mn |
| Mar 31, 2023 | 11.00 Mn |
| Dec 31, 2022 | 9.58 Mn |
| Sep 30, 2022 | 10.09 Mn |
| Jun 30, 2022 | 6.10 Mn |
| Mar 31, 2022 | 21.30 Mn |
| Dec 31, 2021 | 5.82 Mn |
| Sep 30, 2021 | 17.13 Mn |
| Jun 30, 2021 | 25.71 Mn |